Series A startup

Who invested in Perfuse Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$9.0Mraised across 1 round since 2020, from 1 source

Latest round
Series A, $9.0MJul 2020
Investors
1
See who backed them

The rounds

  1. Jul 2020
    Series A$9.0M

    Source recordedSEC filing: $9.0M sold, first sale Jul 2020

Everyone who backed them

OrbiMedPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Perfuse Therapeutics

Who invested in Perfuse Therapeutics?

Perfuse Therapeutics's investors include OrbiMed.

How much has Perfuse Therapeutics raised?

Perfuse Therapeutics has raised $9.0M across 1 round since 2020.

When did Perfuse Therapeutics last raise?

Perfuse Therapeutics's most recent round was a Series A of $9.0M in Jul 2020.

What was Perfuse Therapeutics's biggest round?

Its most recent round, $9.0M in Jul 2020, is also its largest on record.

Who backed Perfuse Therapeutics first?

Perfuse Therapeutics's first round on record, in Jul 2020, was backed by OrbiMed.

What stage is Perfuse Therapeutics at?

Perfuse Therapeutics's latest named round is a Series A, in Jul 2020.

Companies like Perfuse Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.